Free Trial
NASDAQ:MIRA

MIRA Pharmaceuticals (MIRA) Stock Price, News & Analysis

MIRA Pharmaceuticals logo
$1.40 +0.03 (+1.82%)
As of 03:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MIRA Pharmaceuticals Stock (NASDAQ:MIRA)

Key Stats

Today's Range
$1.38
$1.41
50-Day Range
$1.13
$2.02
52-Week Range
$0.73
$2.56
Volume
81,993 shs
Average Volume
1.06 million shs
Market Capitalization
$26.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.00
Consensus Rating
Strong Buy

Company Overview

MIRA Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

MIRA MarketRank™: 

MIRA Pharmaceuticals scored higher than 60% of companies evaluated by MarketBeat, and ranked 431st out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MIRA Pharmaceuticals has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MIRA Pharmaceuticals has received no research coverage in the past 90 days.

  • Read more about MIRA Pharmaceuticals' stock forecast and price target.
  • Earnings Growth

    Earnings for MIRA Pharmaceuticals are expected to grow in the coming year, from ($0.60) to ($0.54) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MIRA Pharmaceuticals is -2.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MIRA Pharmaceuticals is -2.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MIRA Pharmaceuticals has a P/B Ratio of 46.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MIRA Pharmaceuticals' valuation and earnings.
  • Percentage of Shares Shorted

    3.01% of the float of MIRA Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    MIRA Pharmaceuticals has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MIRA Pharmaceuticals has recently decreased by 67.59%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MIRA Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    MIRA Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.01% of the float of MIRA Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    MIRA Pharmaceuticals has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MIRA Pharmaceuticals has recently decreased by 67.59%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MIRA Pharmaceuticals has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for MIRA Pharmaceuticals this week, compared to 1 article on an average week.
  • Search Interest

    Only 4 people have searched for MIRA on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added MIRA Pharmaceuticals to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MIRA Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.65% of the stock of MIRA Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 35.16% of the stock of MIRA Pharmaceuticals is held by institutions.

  • Read more about MIRA Pharmaceuticals' insider trading history.
Receive MIRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MIRA Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MIRA Stock News Headlines

MIRA Pharmaceuticals (NASDAQ:MIRA) Upgraded at Wall Street Zen
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.tc pixel
See More Headlines

MIRA Stock Analysis - Frequently Asked Questions

MIRA Pharmaceuticals' stock was trading at $1.14 at the start of the year. Since then, MIRA shares have increased by 22.4% and is now trading at $1.3950.

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) posted its quarterly earnings results on Thursday, August, 14th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02.

MIRA Pharmaceuticals (MIRA) raised $9 million in an IPO on Thursday, August 3rd 2023. The company issued 1,275,000 shares at a price of $7.00 per share.

MIRA Pharmaceuticals' top institutional shareholders include International Assets Investment Management LLC (0.21%), Creative Planning (0.13%) and XTX Topco Ltd (0.13%). Insiders that own company stock include George Cappy, Erez Aminov and Brian Patrick Mcnulty.
View institutional ownership trends
.

Shares of MIRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MIRA Pharmaceuticals investors own include Plug Power (PLUG), Workhorse Group (WKHS), FuelCell Energy (FCEL), Fortress Biotech (FBIO), Ovid Therapeutics (OVID), Alamos Gold (AGI) and GeoVax Labs (GOVX).

Company Calendar

Last Earnings
8/14/2025
Today
8/28/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MIRA
Previous Symbol
NASDAQ:MIRA
CIK
1904286
Fax
N/A
Employees
2
Year Founded
N/A

Price Target and Rating

High Price Target
$17.00
Low Price Target
$17.00
Potential Upside/Downside
+1,127.4%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.49)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.85 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-406.70%
Return on Assets
-328.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.80
Quick Ratio
2.80

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.03 per share
Price / Book
46.17

Miscellaneous

Outstanding Shares
19,070,000
Free Float
17,801,000
Market Cap
$26.41 million
Optionable
Not Optionable
Beta
1.77

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:MIRA) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners